A65 THE YAP-PER: CAN YAP/TAZ MEDIATE EPITHELIAL-IMMUNE CROSSTALK DURING PYLORIC METAPLASIA?
J Sung, A Gregorieff, S Gruenheid

TL;DR
This study explores how YAP/TAZ proteins influence immune responses and tissue regeneration in the stomach during infection and injury.
Contribution
The study investigates the role of YAP/TAZ in epithelial-immune crosstalk during pyloric metaplasia and H. pylori infection.
Findings
Loss of YAP/TAZ leads to chronic B cell infiltration after tissue injury.
YAP/TAZ deletion results in differential type II immune responses in gastric tissue.
YAP/TAZ may regulate immune responses during both injury and H. pylori infection.
Abstract
Gastric cancer is one of the leading causes of cancer-related deaths and its prevalence has been associated with infection by Helicobacter pylori. H. pylori persistence leads to chronic inflammation, which results in the elimination of acid-secreting parietal cells and the appearance of abnormal mucus-producing cells at the base of the gastric glands, known as spasmolytic polypeptide/trefoil factor 2-expressing metaplasia (SPEM) cells. The processes driving these alterations in epithelial cell fate during H. pylori infection and their function in regeneration of the gastric epithelium remain unclear. Previous work done in our lab have demonstrated that Hippo signalling, more specifically the transcriptional effectors yes-associated protein 1 (YAP) and transcription coactivator with PDZ-binding motif (TAZ), plays an essential role in controlling cell fate during gastric tissue…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGenetic factors in colorectal cancer
